Advertisement

Hellenic Postprandial Lipemia Study (HPLS): Results from the Pre-treatment Postprandial Lipemia

Published:March 10, 2021DOI:https://doi.org/10.1016/j.ejim.2021.02.018
      Although fasting triglyceride (TG) levels are routinely measured in clinical practice, studies indicate that postprandial hypertriglyceridemia may be also related to atherosclerosis [
      • Karpe F
      • Steiner G
      • Uffelman K
      • Olivecrona T
      • Hamsten A.
      Postprandial lipoproteins and progression of coronary atherosclerosis.
      ]. Currently, there are expert panel statements [
      • Kolovou G
      • Watts G
      • Mikhailidis D
      • Perez-Martinez P
      • Mora S
      • Bilianou H
      • Panotopoulos G
      • Katsiki N
      • Ooi CT
      • Lopez-Miranda J
      • Tybjærg-Hansen A
      • Tentolouris N
      • Nordestgaard B.
      Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profiles: executive summary of a 2019 expert panel statement.
      ] and guidelines [
      • Mach
      ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
      ] stating that non-fasting TG levels are clinically valid and that postprandial TG (pTG) measurements may be useful to evaluate cardiovascular (CV) risk.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Karpe F
        • Steiner G
        • Uffelman K
        • Olivecrona T
        • Hamsten A.
        Postprandial lipoproteins and progression of coronary atherosclerosis.
        Atherosclerosis. 1994; 106: 83-97
        • Kolovou G
        • Watts G
        • Mikhailidis D
        • Perez-Martinez P
        • Mora S
        • Bilianou H
        • Panotopoulos G
        • Katsiki N
        • Ooi CT
        • Lopez-Miranda J
        • Tybjærg-Hansen A
        • Tentolouris N
        • Nordestgaard B.
        Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profiles: executive summary of a 2019 expert panel statement.
        Curr Vasc Pharmacol. 2019; 17 (2019 Curr Vasc Pharmacol): 538-540
        • Mach
        ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
        Eur Heart J. 2019; 00: 1-78
        • Tentolouris N
        • Kanellos PT
        • Siami E
        • Athanasopoulou E
        • Chaviaras N
        • Kolovou G
        • Sfikakis PP
        • Katsilambros N.
        Assessment of the validity and reproducibility of a novel standardized test meal for the study of postprandial triacylglycerol concentrations.
        Lipids. 2017; 52: 675-686
        • Gavra P
        • Mellidonis A
        • Iraklianou S
        • Mihas C
        • Kolovou V
        • Mavrogeni S
        • Dimitriadis G
        • Rallidis L
        • Vasaramva K
        • Boutati E
        • Katsiki N
        • Kolovou G.
        Alterations in plasma triglyceride concentrations following two oral meals with different fat content in patients with type 2 diabetes mellitus.
        Curr Vasc Pharmacol. 2018; 16 (Curr Vasc Pharmacol): 385-392
        • Kolovou G
        • Giannakopoulou V
        • Kalogeropoulos P
        • Anagnostopoulou K
        • Goumas G
        • Kazianis G
        • Limberi S
        • Perrea D
        • Mihas C
        • Kolovou V
        • Bilianou H.
        Hellenic Postprandial lipemia study (HPLS): rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease.
        Contemp Clin Trials. 2019; 82: 101-105
        • Perez-Martinez P
        • Alcala-Diaz JF
        • Delgado-Lista J
        • Garcia-Rios A
        • Gomez-Delgado F
        • Marin-Hinojosa C
        • Rodriguez-Cantalejo F
        • Delgado-Casado N
        • Perez-Caballero AI
        • Fuentes-Jimenez FJ
        • Camargo A
        • Tinahones FJ
        • Ordovas JM
        • Perez-Jimenez F
        • Lopez-Miranda J.
        Metabolic phenotypes of obesity influence triglyceride and inflammation homeostasis.
        Eur J Clin Invest. 2014; 44: 1053-1064
        • Wojczynski MK
        • Parnell LD
        • Pollin TI
        • Lai CQ
        • Feitosa MF
        • O'Connell JR
        • et al.
        Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).
        Metabolism. 2015; 64: 1359-1371
        • Lozano A
        • Perez-Martinez P
        • Delgado-Lista J
        • Marin C
        • Cortes B
        • Rodriguez-Cantalejo F
        • Gomez-Luna MJ
        • Cruz-Teno C
        • Perez-Jimenez F
        • Lopez-Miranda J.
        Body mass interacts with fat quality to determine the postprandial lipoprotein response in healthy young adults.
        Nutr Metab Cardiovasc Dis. 2012; 22: 355-361
        • Stampfer MJ
        • Krauss RM
        • Ma J
        • et al.
        A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
        JAMA. 1996; 276: 882-888